Where Do We Draw the Line?

When I saw Dr. M last Monday we ended up talking about medications. I had mentioned to him what I’ve had bad reactions to in the past(Lialda and Imuran) and he mentioned that there were a lot of new medications coming out for IBD. The only one that I was aware of that recently came out was Vedolizumab(Entyvio). He said that he felt that medication was unacceptable because it can cause Progressive Multifocal Leukoencephalopathy(PML) which is a potentially fatal brain infection.

I don’t necessarily trust the FDA to always be able to draw these lines. So we’re going to have to be able to determine this ourselves or our doctors will.┬áSo, where do we draw the line? When do we say that these side effects are too dangerous?